ZURA
Zura Bio Limited Class A Ordinary Shares
NASDAQ: ZURA · HEALTHCARE · BIOTECHNOLOGY
$5.01
-5.47% today
Updated 2026-04-29
Market cap
$502.87M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.06
Dividend yield
—
52W range
$1 – $7
Volume
0.6M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$15.50
+209.38%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-22.30M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-25.74M | $-60.36M | $-52.40M | $-99.35M | $-45.88M |
| EPS | — | — | — | — | $-1.06 |
| Free cash flow | $-13.20M | $-23.05M | $-28.15M | $-64.93M | $-22.30M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Zura Bio Limited Class A Ordinary Shares trades at $5.01. Our Smart Value Score of 24/100 indicates the stock is weak.
Frequently asked questions
What is Zura Bio Limited Class A Ordinary Shares's stock price?
Zura Bio Limited Class A Ordinary Shares (ZURA) trades at $5.01.
Is Zura Bio Limited Class A Ordinary Shares overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Zura Bio Limited Class A Ordinary Shares (ZURA)?
The analyst target price is $15.50, representing +209.4% upside from the current price of $5.01.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-52.50%
Beta0.24
50D MA$6.08
200D MA$4.17
Shares out0.09B
Float0.05B
Short ratio—
Avg volume0.6M
Performance
1 week+1.70%
1 month-9.27%
3 months-16.33%
YTD+2.67%
1 year—
3 years—
5 years—